Chameleon Biosciences was founded in 2017 in California. We have an established lab and leadership team, in addition to our scientific, clinical, and regulatory advisors. Our private laboratory is inside Bonneville Labs, a coworking space for emerging biotechnology companies, community partners, and life science market leaders.
Our exclusive EVADER™ gene delivery platform technology. Innovations developed by Chameleon founders have enabled us to design a potentially more potent, less immunogenic gene therapy that overcomes existing treatment barriers.